Has Justin Mynatt received payments from drug or device companies?

Yes. Drug and device makers reported $7,537 in general payments to Justin Mynatt across 127 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Justin Mynatt did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Justin Mynatt come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Justin Mynatt

Psychiatric/Mental Health · Knoxville, TNNPI 1215371299

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Alkermes, Inc. at 57.3% of the total. Among psychiatric/mental health clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,537in general payments, 2019–2025

Across 127 payments — averaging $59.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$4K
E.r. Squibb & Sons, L.L.C.$1K
Johnson & Johnson$388
Supernus Pharmaceuticals, Inc.$214
AbbVie$174
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$168
plus $853 from 10 others

What the payments were for

Consulting fees$3,33344%
Travel & lodging$1,21116%
Food & beverage$2,99340%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	26	$4,319
E.r. Squibb & Sons, L.L.C.	15	$1,420
Johnson & Johnson	24	$388
Supernus Pharmaceuticals, Inc.	12	$214
AbbVie	3	$174
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	9	$168
Vanda Pharmaceuticals Inc.	4	$150
Otsuka America Pharmaceutical, Inc.	8	$138
Teva Pharmaceuticals USA, Inc.	5	$126
Axsome Therapeutics, Inc.	5	$120
Corium, LLC	4	$90
Neurocrine Biosciences, Inc.	3	$74
Ironshore Pharmaceuticals Inc.	3	$62
Lundbeck LLC	4	$59
Braeburn Inc.	1	$16
Collegium Pharmaceutical, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,537 in reported general payments places this provider in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydroxyzine Hcl	12	$217

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Knoxville

Katherine SullivanKnoxville$17K
Melissa McCarterKnoxville$13K
Melissa SpearsKnoxville$12K
Sarah LordKnoxville$10K
Chenoa ShenandoahKnoxville$10K
Sarah BannisterKnoxville$9K
Brittani ArrowoodKnoxville$9K
Lori HestandKnoxville$8K
Lindsey WondoloskiKnoxville$8K
Laura MelaroBolivar$682K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →